The promise and peril of chemical probes
C.H. Arrowsmith(University Health Network), Michael A. Walters(University of Minnesota), Adrian J. Carter(Boehringer Ingelheim (Germany)), Bryan L. Roth(University of North Carolina at Chapel Hill), Mathias Frederiksen(Novartis (Switzerland)), Brian K. Shoichet(University of California, San Francisco), M. Sundström(Karolinska University Hospital), Philip Cohen(MRC Protein Phosphorylation and Ubiquitylation Unit), Brian D. Marsden(Centre for Human Genetics), Stefan Knapp(Goethe University Frankfurt), Jonathan P. Bennett(Merck & Co., Inc., Rahway, NJ, USA (United States)), A.M. Edwards(University of Toronto), Trevor Howe(Janssen (United Kingdom)), Rónán C. O’Hagan(Merck & Co., Inc., Rahway, NJ, USA (United States)), C. Bountra(University of Oxford), Nathanael S. Gray(Stanford University), James E. Audia(Therapeutics Clinical Research), Charles E. Grimshaw(Takeda (United States)), Stephen V. Frye(University of North Carolina at Chapel Hill), Jian Jin(Icahn School of Medicine at Mount Sinai), Stuart L. Schreiber(Broad Institute), Dashyant Dhanak(Wilmington University), Jayme L. Dahlin(Brigham and Women's Hospital), Chris Walpole(Structural Genomics Consortium), Jonathan B. Baell(Nanjing Tech University), Christopher P. Austin(Unknown), Dafydd R. Owen(Pfizer (United States)), Jack Taunton(University of British Columbia), Julian Blagg(Altrincham Hospital), Mark E. Bunnage(Vertex Pharmaceuticals (United States)), Susanne Müller(Goethe University Frankfurt), Carolyn Buser‐Doepner(GlaxoSmithKline (United States)), K. Huber(Austrian Academy of Sciences), Ruth A. Ross(University of Toronto), Robert A. Copeland(Unknown), David Hepworth(Pfizer (United States)), Leticia Toledo‐Sherman(CHDI Foundation), Matthieu Schapira(University of Toronto), Ben Cravatt(Scripps Research Institute), Paul E. Brennan(Discovery Centre), Mary M. Mader(Eli Lilly (United States)), Peter J. Brown(University of Toronto), Derek Lowe(Vertex Pharmaceuticals (United States)), Ryan G. Kruger(Arysta LifeScience (France)), Anke Mueller‐Fahrnow(Bayer (Germany)), Giulio Superti-Furga(Austrian Academy of Sciences), John P. Overington(Hunter College), Saul H. Rosenberg(Abbott Fund), Joanne Kotz(Broad Institute)
Cited by 848
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k